Home NDC 0078-0979 MAYZENT
Product NDC 0078-0979
11-digit product format 000780979
Labeler code 0078
Product ID 0078-0979_905dd6df-a774-4f5c-aa7a-f21c79944ed6
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name siponimod
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Novartis Pharmaceuticals Corporation
Application NDA209884
Marketing category NDA
Marketing start 2019-03-26
Substance SIPONIMOD
Active strength .25 mg/1
Pharmacologic classes Sphingosine 1-Phosphate Receptor Modulators [MoA], Sphingosine 1-phosphate Receptor Modulator [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N209884-001 MAYZENT SIPONIMOD EQ 0.25MG BASE TABLET / ORAL RLD 2019-03-26 N209884-002 MAYZENT SIPONIMOD EQ 2MG BASE TABLET / ORAL RLD, RS 2019-03-26 N209884-003 MAYZENT SIPONIMOD EQ 1MG BASE TABLET / ORAL RLD 2021-08-24
Orange Book patents# Current patent rows page 1 of 1 · 15 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N209884-001 7939519 2028-08-27 Drug substance, Drug product 2019-04-19 N209884-001 8492441 2030-11-30 U-2511 2019-04-19 N209884-001 12071402 2032-01-05 Drug product 2024-09-26 N209884-001 11944602 2036-04-23 U-3889 2024-04-30 N209884-001 12533340 2036-04-23 U-4407 2026-02-13 N209884-002 7939519 2028-08-27 Drug substance, Drug product 2019-04-19 N209884-002 8492441 2030-11-30 U-2511 2019-04-19 N209884-002 12071402 2032-01-05 Drug product 2024-09-26 N209884-002 11944602 2036-04-23 U-3889 2024-04-30 N209884-002 12533340 2036-04-23 U-4407 2026-02-13 N209884-003 7939519 2028-08-27 Drug substance, Drug product 2021-09-22 N209884-003 8492441 2030-11-30 U-2511 2021-09-22 N209884-003 12071402 2032-01-05 Drug product 2024-09-26 N209884-003 11944602 2036-04-23 U-3889 2024-04-30 N209884-003 12533340 2036-04-23 U-4407 2026-02-13
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 115 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N209884-001 MAYZENT EQ 0.25MG BASE TABLET / ORAL RLD 2019-03-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209884-002 MAYZENT EQ 2MG BASE TABLET / ORAL RLD, RS 2019-03-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209884-003 MAYZENT EQ 1MG BASE TABLET / ORAL RLD 2021-08-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209884-001 MAYZENT EQ 0.25MG BASE TABLET / ORAL RLD 2019-03-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209884-002 MAYZENT EQ 2MG BASE TABLET / ORAL RLD, RS 2019-03-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209884-003 MAYZENT EQ 1MG BASE TABLET / ORAL RLD 2021-08-24 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209884-001 MAYZENT EQ 0.25MG BASE TABLET / ORAL RLD 2019-03-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209884-002 MAYZENT EQ 2MG BASE TABLET / ORAL RLD, RS 2019-03-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209884-003 MAYZENT EQ 1MG BASE TABLET / ORAL RLD 2021-08-24 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209884-001 MAYZENT EQ 0.25MG BASE TABLET / ORAL RLD 2019-03-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209884-002 MAYZENT EQ 2MG BASE TABLET / ORAL RLD, RS 2019-03-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209884-003 MAYZENT EQ 1MG BASE TABLET / ORAL RLD 2021-08-24 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209884-001 MAYZENT EQ 0.25MG BASE TABLET / ORAL RLD 2019-03-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209884-002 MAYZENT EQ 2MG BASE TABLET / ORAL RLD, RS 2019-03-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209884-003 MAYZENT EQ 1MG BASE TABLET / ORAL RLD 2021-08-24 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209884-001 MAYZENT EQ 0.25MG BASE TABLET / ORAL RLD 2019-03-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209884-002 MAYZENT EQ 2MG BASE TABLET / ORAL RLD, RS 2019-03-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209884-003 MAYZENT EQ 1MG BASE TABLET / ORAL RLD 2021-08-24 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209884-001 MAYZENT EQ 0.25MG BASE TABLET / ORAL RLD 2019-03-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209884-002 MAYZENT EQ 2MG BASE TABLET / ORAL RLD, RS 2019-03-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209884-003 MAYZENT EQ 1MG BASE TABLET / ORAL RLD 2021-08-24 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209884-001 MAYZENT EQ 0.25MG BASE TABLET / ORAL RLD 2019-03-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209884-002 MAYZENT EQ 2MG BASE TABLET / ORAL RLD, RS 2019-03-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209884-003 MAYZENT EQ 1MG BASE TABLET / ORAL RLD 2021-08-24 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209884-001 MAYZENT EQ 0.25MG BASE TABLET / ORAL RLD 2019-03-26 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209884-002 MAYZENT EQ 2MG BASE TABLET / ORAL RLD, RS 2019-03-26 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209884-003 MAYZENT EQ 1MG BASE TABLET / ORAL RLD 2021-08-24 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N209884-001 MAYZENT EQ 0.25MG BASE TABLET / ORAL RLD 2019-03-26 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N209884-002 MAYZENT EQ 2MG BASE TABLET / ORAL RLD, RS 2019-03-26 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N209884-003 MAYZENT EQ 1MG BASE TABLET / ORAL RLD 2021-08-24 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209884-001 MAYZENT EQ 0.25MG BASE TABLET / ORAL RLD 2019-03-26 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209884-002 MAYZENT EQ 2MG BASE TABLET / ORAL RLD, RS 2019-03-26 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209884-003 MAYZENT EQ 1MG BASE TABLET / ORAL RLD 2021-08-24 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N209884-001 MAYZENT EQ 0.25MG BASE TABLET / ORAL RLD 2019-03-26 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N209884-002 MAYZENT EQ 2MG BASE TABLET / ORAL RLD, RS 2019-03-26 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N209884-003 MAYZENT EQ 1MG BASE TABLET / ORAL RLD 2021-08-24 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N209884-001 MAYZENT EQ 0.25MG BASE TABLET / ORAL RLD 2019-03-26 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N209884-002 MAYZENT EQ 2MG BASE TABLET / ORAL RLD, RS 2019-03-26 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N209884-003 MAYZENT EQ 1MG BASE TABLET / ORAL RLD 2021-08-24 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N209884-001 MAYZENT EQ 0.25MG BASE TABLET / ORAL RLD 2019-03-26 8072bd15b7f6…
Observed Orange Book patent history# Patent history page 1 of 8 · 308 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N209884-001 7939519 2028-08-27 Drug substance, Drug product 2019-04-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209884-001 8492441 2030-11-30 U-2511 2019-04-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209884-001 12071402 2032-01-05 Drug product 2024-09-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209884-001 11944602 2036-04-23 U-3889 2024-04-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209884-002 7939519 2028-08-27 Drug substance, Drug product 2019-04-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209884-002 8492441 2030-11-30 U-2511 2019-04-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209884-002 12071402 2032-01-05 Drug product 2024-09-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209884-002 11944602 2036-04-23 U-3889 2024-04-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209884-003 7939519 2028-08-27 Drug substance, Drug product 2021-09-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209884-003 8492441 2030-11-30 U-2511 2021-09-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209884-003 12071402 2032-01-05 Drug product 2024-09-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209884-003 11944602 2036-04-23 U-3889 2024-04-30 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209884-001 7939519 2028-08-27 Drug substance, Drug product 2019-04-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209884-001 8492441 2030-11-30 U-2511 2019-04-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209884-001 12071402 2032-01-05 Drug product 2024-09-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209884-001 11944602 2036-04-23 U-3889 2024-04-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209884-002 7939519 2028-08-27 Drug substance, Drug product 2019-04-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209884-002 8492441 2030-11-30 U-2511 2019-04-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209884-002 12071402 2032-01-05 Drug product 2024-09-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209884-002 11944602 2036-04-23 U-3889 2024-04-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209884-003 7939519 2028-08-27 Drug substance, Drug product 2021-09-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209884-003 8492441 2030-11-30 U-2511 2021-09-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209884-003 12071402 2032-01-05 Drug product 2024-09-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209884-003 11944602 2036-04-23 U-3889 2024-04-30 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209884-001 7939519 2028-08-27 Drug substance, Drug product 2019-04-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209884-001 8492441 2030-11-30 U-2511 2019-04-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209884-001 12071402 2032-01-05 Drug product 2024-09-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209884-001 11944602 2036-04-23 U-3889 2024-04-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209884-002 7939519 2028-08-27 Drug substance, Drug product 2019-04-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209884-002 8492441 2030-11-30 U-2511 2019-04-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209884-002 12071402 2032-01-05 Drug product 2024-09-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209884-002 11944602 2036-04-23 U-3889 2024-04-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209884-003 7939519 2028-08-27 Drug substance, Drug product 2021-09-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209884-003 8492441 2030-11-30 U-2511 2021-09-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209884-003 12071402 2032-01-05 Drug product 2024-09-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209884-003 11944602 2036-04-23 U-3889 2024-04-30 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209884-001 7939519 2028-08-27 Drug substance, Drug product 2019-04-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209884-001 8492441 2030-11-30 U-2511 2019-04-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209884-001 12071402 2032-01-05 Drug product 2024-09-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209884-001 11944602 2036-07-24 U-3889 2024-04-30 fd3edfee7708…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 5 · 178 observed states.
Additional Listing Data#
Finished product Yes
Brand name base MAYZENT
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength SIPONIMOD .25 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination RR6P8L282I Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 10 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2121090 Internal RxNorm lookup 2121096 Internal RxNorm lookup 2121098 Internal RxNorm lookup 2121100 Internal RxNorm lookup 2123313 Internal RxNorm lookup 2123314 Internal RxNorm lookup 2594606 Internal RxNorm lookup 2594608 Internal RxNorm lookup 2594796 Internal RxNorm lookup 2594797 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# NDC, Effective, Related label table NDC Effective Related label 0078-0979-12 2023-08-01 These highlights do not include all the information needed to use MAYZENT safely and effectively. See full prescribing information for MAYZENT. MAYZENT ® (siponimod) tablets, for oral use Initial U.S. Approval: 2019 0078-0979-12 2023-08-01 These highlights do not include all the information needed to use MAYZENT safely and effectively. See full prescribing information for MAYZENT. MAYZENT ® (siponimod) tablets, for oral use Initial U.S. Approval: 2019 0078-0979-50 2023-08-01 These highlights do not include all the information needed to use MAYZENT safely and effectively. See full prescribing information for MAYZENT. MAYZENT ® (siponimod) tablets, for oral use Initial U.S. Approval: 2019 0078-0979-50 2023-08-01 These highlights do not include all the information needed to use MAYZENT safely and effectively. See full prescribing information for MAYZENT. MAYZENT ® (siponimod) tablets, for oral use Initial U.S. Approval: 2019 0078-0979-89 2023-08-01 These highlights do not include all the information needed to use MAYZENT safely and effectively. See full prescribing information for MAYZENT. MAYZENT ® (siponimod) tablets, for oral use Initial U.S. Approval: 2019 0078-0979-89 2023-08-01 These highlights do not include all the information needed to use MAYZENT safely and effectively. See full prescribing information for MAYZENT. MAYZENT ® (siponimod) tablets, for oral use Initial U.S. Approval: 2019 0078-0979-92 2023-08-01 These highlights do not include all the information needed to use MAYZENT safely and effectively. See full prescribing information for MAYZENT. MAYZENT ® (siponimod) tablets, for oral use Initial U.S. Approval: 2019 0078-0979-92 2023-08-01 These highlights do not include all the information needed to use MAYZENT safely and effectively. See full prescribing information for MAYZENT. MAYZENT ® (siponimod) tablets, for oral use Initial U.S. Approval: 2019 0078-0979-12 2023-07-28 These highlights do not include all the information needed to use MAYZENT safely and effectively. See full prescribing information for MAYZENT. MAYZENT ® (siponimod) tablets, for oral use Initial U.S. Approval: 2019 0078-0979-12 2023-07-28 These highlights do not include all the information needed to use MAYZENT safely and effectively. See full prescribing information for MAYZENT. MAYZENT ® (siponimod) tablets, for oral use Initial U.S. Approval: 2019 0078-0979-50 2023-07-28 These highlights do not include all the information needed to use MAYZENT safely and effectively. See full prescribing information for MAYZENT. MAYZENT ® (siponimod) tablets, for oral use Initial U.S. Approval: 2019 0078-0979-50 2023-07-28 These highlights do not include all the information needed to use MAYZENT safely and effectively. See full prescribing information for MAYZENT. MAYZENT ® (siponimod) tablets, for oral use Initial U.S. Approval: 2019 0078-0979-89 2023-07-28 These highlights do not include all the information needed to use MAYZENT safely and effectively. See full prescribing information for MAYZENT. MAYZENT ® (siponimod) tablets, for oral use Initial U.S. Approval: 2019 0078-0979-89 2023-07-28 These highlights do not include all the information needed to use MAYZENT safely and effectively. See full prescribing information for MAYZENT. MAYZENT ® (siponimod) tablets, for oral use Initial U.S. Approval: 2019 0078-0979-92 2023-07-28 These highlights do not include all the information needed to use MAYZENT safely and effectively. See full prescribing information for MAYZENT. MAYZENT ® (siponimod) tablets, for oral use Initial U.S. Approval: 2019 0078-0979-92 2023-07-28 These highlights do not include all the information needed to use MAYZENT safely and effectively. See full prescribing information for MAYZENT. MAYZENT ® (siponimod) tablets, for oral use Initial U.S. Approval: 2019
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0078-0979-12 MAYZENT 12 in 1 BLISTER PACK TABLET, FILM COATED 12 16 0078-0979-50 MAYZENT 28 in 1 BOTTLE TABLET, FILM COATED 28 16 0078-0979-89 MAYZENT 7 in 1 BLISTER PACK TABLET, FILM COATED 7 16 0078-0979-92 MAYZENT 28 in 1 BOTTLE TABLET, FILM COATED 28 16
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0078-0979 MAYZENT (SIPONIMOD) TABLET, FILM COATED [NOVARTIS PHARMACEUTICALS CORPORATION] 14 Current NDC, Legacy NDC, 4 package rows 20240724_44492772-5aed-4627-bd85-e8e89f308bb3.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join MAYZENT SIPONIMOD Novartis Pharmaceuticals Corporation 44492772-5aed-4627-bd85-e8e89f308bb3 2026-06-30 Warnings, Adverse reactions Exact identifier application applno (NDA): 209884 application number: NDA209884 ndc (product): 0078-0979
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0078-0979-12 00078097912 12 TABLET, FILM COATED in 1 BLISTER PACK (0078-0979-12) 2019-03-26 0000-00-00 No No Current 0078-0979-50 00078097950 28 TABLET, FILM COATED in 1 BOTTLE (0078-0979-50) 2019-03-26 0000-00-00 No No Current 0078-0979-89 00078097989 7 TABLET, FILM COATED in 1 BLISTER PACK (0078-0979-89) 2022-03-01 0000-00-00 No No Current 0078-0979-92 00078097992 28 TABLET, FILM COATED in 1 BOTTLE (0078-0979-92) 2019-03-26 0000-00-00 Yes No Current